Ascendis Pharma A/S (ASND)

215.05 +6.29 (+3.01%) USD  |  NASDAQ  |  Jan 13, 16:00
214.98 -0.07 (-0.03%) Pre-Market: 08:36
More

Ascendis Pharma Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Novo Nordisk A/S Upgrade
Evaxion AS Upgrade
DBV Technologies SA Upgrade
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc Upgrade